Feasibility Study of the Intensive Systolic Blood Pressure Control

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02817503

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02817503
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02817503. Randomized; single masking; primary purpose treatment. Start 2015-12 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Feasibility Study of the Intensive Systolic Blood Pressure Control
Condition
Hypertension
Condition
Hyperhomocysteinemia
Intervention (Drug)
Standard BP control
Intervention (Drug)
Moderate BP control
Intervention (Drug)
Intensive BP control
Lead sponsor
Second Affiliated Hospital of Nanchang University (class: other)
Collaborator
Peking University First Hospital (class: other)

Record details

Record id
cardio:ct-nct02817503
Content hash
e36c86a329f98f7b9f7784f768c3907b0a6bbf1dcd64517d1db67bedcdf8cbe0